Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hellwig

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
EJNMMI Research|March 17, 2025
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphomaMichael Beck, Viktoria Blumenberg, Veit L Bücklein, et al.
Nuklearmedizin. Nuclear Medicine|April 7, 2022
Radiation doses from low-dose CT scans in SPECT/CT and PET/CT examinations: A survey in GermanyAndreas Rinscheid, Tilman Janzen, Babak Alikhani, et al.
Nature Communications|March 5, 2021
Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitisJames A Hutchinson, Katharina Kronenberg, Paloma Riquelme, et al.
Molecular Oncology|October 5, 2024
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patientsNataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, et al.
Journal of Medical Internet Research|April 15, 2025
Bridging Data Silos in Oncology with Modular Software for Federated Analysis on Fast Healthcare Interoperability Resources: Multisite Implementation StudyJasmin Ziegler, Marcel Pascal Erpenbeck, Timo Fuchs, et al.
Molecular Imaging and Biology|March 27, 2014
Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, GermanyDale L Bailey, Henryk Barthel, Bettina Beuthin-Baumann, et al.
The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.
Cancer Cell|February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityLukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
EJNMMI Research|March 17, 2025
Liver-FDG-uptake augments early PET/CT prognostic value for CD19-targeted CAR-T cell therapy in diffuse large B cell lymphomaMichael Beck, Viktoria Blumenberg, Veit L Bücklein, et al.
Nuklearmedizin. Nuclear Medicine|April 7, 2022
Radiation doses from low-dose CT scans in SPECT/CT and PET/CT examinations: A survey in GermanyAndreas Rinscheid, Tilman Janzen, Babak Alikhani, et al.
Nature Communications|March 5, 2021
Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitisJames A Hutchinson, Katharina Kronenberg, Paloma Riquelme, et al.
Molecular Oncology|October 5, 2024
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patientsNataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, et al.
Journal of Medical Internet Research|April 15, 2025
Bridging Data Silos in Oncology with Modular Software for Federated Analysis on Fast Healthcare Interoperability Resources: Multisite Implementation StudyJasmin Ziegler, Marcel Pascal Erpenbeck, Timo Fuchs, et al.
Molecular Imaging and Biology|March 27, 2014
Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, GermanyDale L Bailey, Henryk Barthel, Bettina Beuthin-Baumann, et al.
The Lancet. Oncology|June 27, 2024
Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trialSelim Corbacioglu, Holger Lode, Susanne Ellinger, et al.
Cancer Cell|February 11, 2025
Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunityLukas M Braun, Sophie Giesler, Geoffroy Andrieux, et al.
Pageof 8